Continuous glucose monitor from Medtronic wins EU approval

12/5/2012 | Star Tribune (Minneapolis-St. Paul, Minn.)

Medtronic has earned CE mark approval to market its Sentrino device in Europe. The technology, which is used to monitor a patient's glucose levels continuously and less invasively, is billed as the first such device designed for use in hospital critical care units.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL